BLEOMICINA ACCORD 15000UI powder for injection / infusion solution medication leaflet

L01DC01 • bleomycin sulfate • Antineoplastic and immunomodulating agents | Cytotoxic antibiotics and related substances | Other cytotoxic antibiotics

Bleomycinum sulfas is a medication used in the treatment of certain types of cancer, including Hodgkin's lymphoma, non-Hodgkin's lymphoma, squamous cell carcinoma, and testicular cancer. It belongs to the class of cytotoxic antibiotics and works by damaging the DNA of cancer cells, thereby inhibiting their growth and division.

The medication is usually administered via intravenous, intramuscular, or subcutaneous injection, as directed by a doctor. The dosage and duration of treatment depend on the type of cancer and the patient's overall condition.

Common side effects include fever, chills, nausea, vomiting, and loss of appetite. In rare cases, bleomycinum sulfas can cause pulmonary toxicity, manifested as difficulty breathing or persistent cough, which is why patients must be closely monitored.

Bleomycinum sulfas is not recommended for pregnant or breastfeeding women, as it may affect fetal development. Patients should inform their doctor about any other medications they are taking to avoid drug interactions.